Diabetes Drug
-
{
- All
- News
- Videos
- Web Stories
-
More Weight Loss While On Ozempic Means Lower Risk Of Obesity-Related Diseases, Says New Study
The new analysis suggests that greater weight loss achieved while taking Ozempic and similar GLP-1 medications may lead to a larger reduction in obesity-related disease risk.
-
Wegovy Pill Users Lost Up To 21.6% Weight In New Obesity Trial
The findings come from Novo Nordisk's phase 3 OASIS 4 clinical trial studying oral semaglutide 25 mg, the same active ingredient used in injectable Wegovy.
-
GLP-1 Drugs May Trigger Muscle Loss In Cirrhosis Patients: Study
GLP-1 drugs are often praised for their metabolic benefits, including improved blood sugar control and weight reduction. However, in patients with liver cirrhosis, these benefits may come with trade-offs.
-
Beyond GLP-1: New 5-In-1 Compound More Effective Than Semaglutide For Diabetes And Weight Loss
This innovative compound is known as a 'quintuple agonist' because it combines the power of GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) receptor agonists with lanifibranor.
-
Dr Reddy's Wins Nod to Sell Generic Ozempic, Check Cost Of Weight-Loss Drug
The entry of Dr Reddy's generic is triggering a price battle among pharmaceutical companies worldwide.
-
Fake Mounjaro Worth Rs 56 Lakh Seized In Gurugram: What It Can Do To Your Body
Fake Mounjaro injections seized in Gurugram highlight rising counterfeit weight-loss drug risks and severe health dangers.
-
On Ozempic Or Wegovy? Doctors Say Stop Before Surgery, Here's Why
The ASA guidance suggests that patients on GLP-1 drugs should consult their healthcare providers well in advance of any planned surgery.
-
Popular Weight Loss Drugs May Lead To More Muscle Loss, Finds Study
The study analysed multiple studies and found that muscle-related tissue accounted for about 35% of total weight lost in incretin groups, exceeding safe benchmarks in two-thirds of cases.
-
From Ozempic To Bariatric Surgery, Delhi Doctor Ranks 7 Weight-Loss Methods
Not everyone can or should opt for Ozempic, Mounjaro, or bariatric surgery for weight loss. The doctor lists seven methods and explains who they suit best
-
Diabetes Drug Metformin Could Reduce Insulin Needs For People With Type 1 Diabetes: Study
Researchers tested the drug on 40 adults with long-term type 1 diabetes in the Insulin Resistance in Type 1 Diabetes Managed with Metformin (INTIMET) study, giving half of them metformin and half a placebo for six months.
-
Is Erectile Dysfunction A Side Effect Of Taking Weight-Loss Drugs? New Trial Results Say Yes
A new study links GLP-1 drugs, used for diabetes and weight loss, to a higher risk of erectile dysfunction.
-
Novo Nordisk Partners With OpenAI To Accelerate Drug Discovery
The company said Artificial Intelligence will be used to analyse complex datasets, identify potential drug candidates and reduce the time taken to move from research to clinical application.
-
New Study Explains Why Ozempic Doesn't Work For Everyone
A new study published in Genome Medicine details that Ozempic doesn't work for everyone in the same manner. Here is what you need to know about its mechanisms and why making science-based medical decisions is important.
-
Struggling To Lose Weight On Ozempic, Mounjaro? Study Says Your Genes Might Be the Hurdle
A new study reveals that your genes could be the hidden hurdle, explaining the differences in how bodies respond to weight loss drugs.
-
End-Stage Heart Disease: Cardiologists Share When A Heart Transplant Becomes The Only Lifeline
End-stage heart disease can leave patients breathless and fatigued despite treatment. Experts explain dilated cardiomyopathy, warning signs, and when a heart transplant becomes necessary, offering a second chance at life.
-
More Weight Loss While On Ozempic Means Lower Risk Of Obesity-Related Diseases, Says New Study
The new analysis suggests that greater weight loss achieved while taking Ozempic and similar GLP-1 medications may lead to a larger reduction in obesity-related disease risk.
-
Wegovy Pill Users Lost Up To 21.6% Weight In New Obesity Trial
The findings come from Novo Nordisk's phase 3 OASIS 4 clinical trial studying oral semaglutide 25 mg, the same active ingredient used in injectable Wegovy.
-
GLP-1 Drugs May Trigger Muscle Loss In Cirrhosis Patients: Study
GLP-1 drugs are often praised for their metabolic benefits, including improved blood sugar control and weight reduction. However, in patients with liver cirrhosis, these benefits may come with trade-offs.
-
Beyond GLP-1: New 5-In-1 Compound More Effective Than Semaglutide For Diabetes And Weight Loss
This innovative compound is known as a 'quintuple agonist' because it combines the power of GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) receptor agonists with lanifibranor.
-
Dr Reddy's Wins Nod to Sell Generic Ozempic, Check Cost Of Weight-Loss Drug
The entry of Dr Reddy's generic is triggering a price battle among pharmaceutical companies worldwide.
-
Fake Mounjaro Worth Rs 56 Lakh Seized In Gurugram: What It Can Do To Your Body
Fake Mounjaro injections seized in Gurugram highlight rising counterfeit weight-loss drug risks and severe health dangers.
-
On Ozempic Or Wegovy? Doctors Say Stop Before Surgery, Here's Why
The ASA guidance suggests that patients on GLP-1 drugs should consult their healthcare providers well in advance of any planned surgery.
-
Popular Weight Loss Drugs May Lead To More Muscle Loss, Finds Study
The study analysed multiple studies and found that muscle-related tissue accounted for about 35% of total weight lost in incretin groups, exceeding safe benchmarks in two-thirds of cases.
-
From Ozempic To Bariatric Surgery, Delhi Doctor Ranks 7 Weight-Loss Methods
Not everyone can or should opt for Ozempic, Mounjaro, or bariatric surgery for weight loss. The doctor lists seven methods and explains who they suit best
-
Diabetes Drug Metformin Could Reduce Insulin Needs For People With Type 1 Diabetes: Study
Researchers tested the drug on 40 adults with long-term type 1 diabetes in the Insulin Resistance in Type 1 Diabetes Managed with Metformin (INTIMET) study, giving half of them metformin and half a placebo for six months.
-
Is Erectile Dysfunction A Side Effect Of Taking Weight-Loss Drugs? New Trial Results Say Yes
A new study links GLP-1 drugs, used for diabetes and weight loss, to a higher risk of erectile dysfunction.
-
Novo Nordisk Partners With OpenAI To Accelerate Drug Discovery
The company said Artificial Intelligence will be used to analyse complex datasets, identify potential drug candidates and reduce the time taken to move from research to clinical application.
-
New Study Explains Why Ozempic Doesn't Work For Everyone
A new study published in Genome Medicine details that Ozempic doesn't work for everyone in the same manner. Here is what you need to know about its mechanisms and why making science-based medical decisions is important.
-
Struggling To Lose Weight On Ozempic, Mounjaro? Study Says Your Genes Might Be the Hurdle
A new study reveals that your genes could be the hidden hurdle, explaining the differences in how bodies respond to weight loss drugs.
-
End-Stage Heart Disease: Cardiologists Share When A Heart Transplant Becomes The Only Lifeline
End-stage heart disease can leave patients breathless and fatigued despite treatment. Experts explain dilated cardiomyopathy, warning signs, and when a heart transplant becomes necessary, offering a second chance at life.
